Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc. Common Stock (BCAX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BCAX · as of Jun 8, 2026
Key Statistics
Explore Bicara Therapeutics Inc. Common Stock Data
bcax stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
The BCAX analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $28.60, representing +42.29% upside from the current price of $20.10.
Competitors & Peers
bcax competitorsBCAX
EYPT
FTRE
KURA
MRVI
PHATStock Performance
Full HistoryAbout Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Inc. Common Stock Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, du…
what is bicara therapeutics inc. common stock · bcax stock overview · bicara therapeutics inc. common stock company profile · who is bicara therapeutics inc. common stock ceo · bcax NASDAQ · bicara therapeutics inc. common stock headquarters · bicara therapeutics inc. common stock business segments
About Stock Overview & Key Data
Bicara Therapeutics Inc. Common Stock (BCAX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 13, 2024. As of the latest trading session, BCAX stock price is $20.10, with a market capitalization of $1.1B. The stock has returned +75.09% over the past 12 months and +19.43% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Bicara Therapeutics Inc. Common Stock stock is Buy, with an average 12-month price target of $28.60. In fiscal year 2025, Bicara Therapeutics Inc. Common Stock reported revenue of — and net income of -$137.9M. For detailed data — including Bicara Therapeutics Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bicara Therapeutics Inc. Common Stock (BCAX) stock price is $20.10. The stock is traded on NASDAQ under the ticker symbol BCAX. The 52-week range is $8.48 – $24.25.